Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.48 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.47 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | ELANE | P08246 | 4/20 | 0.44 |
| ▸ | CTSG | P08311 | 2/20 | 0.44 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.43 |
| ▸ | HTT | P42858 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | APAF1 | O14727 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | STAT6 | P42226 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL543220 | 0.92 | ELANE (0.42) | TLR8NR1H2NR1H3MAPTPTPN1 | |
| SCHEMBL543218 | 0.86 | NPC1 (0.42) | TLR8MAPTELANECTSGKDM4E | |
| SCHEMBL5010709 | 0.86 | TLR8 (0.56) | TLR8NR1H2NR1H3MAPTLIPG | |
| SCHEMBL6661787 | 0.86 | TLR8 (0.56) | TLR8NR1H2NR1H3MAPTLIPG | |
| SCHEMBL11227235 | 0.86 | TLR8 (0.59) | TLR8NR1H2NR1H3MAPTLIPG | |
| SCHEMBL11229645 | 0.86 | TLR8 (0.59) | TLR8NR1H2NR1H3MAPTLIPG | |
| SCHEMBL17998809 | 0.85 | MAPT (0.48) | TLR8NR1H2NR1H3MAPTPTPN1 | |
| SCHEMBL17998808 | 0.84 | GPR3 (0.48) | MAPTPTPN1GPR3 | |
| SCHEMBL28046693 | 0.84 | TLR8 (0.61) | TLR8NR1H2NR1H3MAPTLIPG | |
| SCHEMBL543741 | 0.81 | NPC1 (0.50) | MAPTELANEMEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1719749-B1 | POLYACENE COMPOUND AND ORGANIC SEMICONDUCTOR THIN FILM | ASAHI CHEMICAL IND (JP) | 2016-08-24 | — | — | EP | disclosed |
| US-8236998-B2 | Polyacene compound and organic semiconductor thin film | ASAHI KASEI CORPORATION (JP) | 2012-08-07 | — | — | US | disclosed |
| US-20120108850-A1 | POLYACENE COMPOUND AND ORGANIC SEMICONDUCTOR THIN FILM | NAGATA KAZUTO (JP) | 2012-05-03 | — | — | US | disclosed |
| US-8110714-B2 | High mobility, solubility, oxidation resistance; transistor; drain electrodes | ASAHI KASEI CORPORATION (JP) | 2012-02-07 | — | — | US | disclosed |
| US-20080061287-A1 | Polyacene Compound And Organic Semiconductor Thin Film | ASAHI KASEI CORPORATION (JP) | 2008-03-13 | — | — | US | disclosed |
| EP-1719749-A1 | POLYACENE COMPOUND AND ORGANIC SEMICONDUCTOR THIN FILM | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 2006-11-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108850-A1 | POLYACENE COMPOUND AND ORGANIC SEMICONDUCTOR THIN FILM | ZRANB2, PUF60, ZKSCAN2 | TLR8 1352/4885NR1H2 3791/4885NR1H3 3476/4885 |
| US-20080061287-A1 | Polyacene Compound And Organic Semiconductor Thin Film | ZRANB2, PUF60, ZKSCAN2 | TLR8 1352/4885NR1H2 3791/4885NR1H3 3476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.